2nd Day Program

Plenary Session: Clinical Innovation in Patient Centered Care

@Grand Ball Room

Moderator: Derek Stewart
Type of Session: Knowledge – Based

Session Program:

Time Topic
08:00-08:20 Impact of Clinician Burnout on Patient Safety: Journey to a Resilient & Thriving Healthcare Workforce

Paul Bush, Pharm.D., M.B.A., BCPS, FASHP Vice President, Global Business Development and Consulting American Society of Health System Pharmacists
08:20-08:40 Patient Centered Pharmacy Practice: Clinical Innovation and Shift of Practice

Osama Tabbara, R.Ph, EMBA President, IVPN-Network Pharmacy Consultant | Entrepreneur | Mentor
08:40-09:00 A Journey to Zero preventable Harm from Medications

Carolyn Hoffman RN MN, President and CEO Institute for Safe Medication Practices Canada (ISMP Canada) System
09:00-09:20 Patient Centered Service Design and Provision

Sherif Kamal RPh,MSc, DHCM Pharmacy Programs Director, Children Cancer Hospital .Egypt
09:20-09:40 Discussion
09:40-11:00 Coffee Break

Parallel Session: Patient Safety in Oman: Achievements and Breakthrough

@Grand Ball Room (Hall A)

Moderator: Ibrahim AlRashdi
Type of Session: Knowledge – Based

Session Program:

Time Topic
11:00-11:15 Analysis of adverse drug reactions due to covid-19 vaccine at a tertiary care hospital (SQUH) in Oman

Alsayyida Bushra Albusaidi, senior pharmacist SQUH, Muscat
11:15- 11:30 Safe practice influenced by clinical pharmacist co-led anti coagulation clinic

Nadiya Albulushi, Specialized pharmacist, DGQAC, MOH, Oman
11:30-11:45 Poison Prevention & Patient Safety “The Role of Poisoning Centres”

Badria Alhatali, MD,FACMT Head of Poison Control Section, Department of Environmental and Occupational Health, Directorate General of Disease Surveillance and Control. Ministry of Health. Emergency Medicine Consultant at Royal Hospital Middle East and North Africa Clinical Toxicology Association (MENATOX)president
11:45-12:00 Cost and Clinical Implication of Clinical Pharmacist Interactions on Antimicrobial Use at Sultan Qaboos Hospital

Bushra Al-lawati, Clinical Pharmacist, Sultan Qaboos university Hospital, Oman
12:00-12:15 Sohar Hospital Patient Safety Improvement Process” pharmacy Prospective”

Ahmed AlZaabi, Clinical pharmacist, Sohar Hospital ,Oman
12:15-12:30 Discussion
12:30-12:45 Incidence of Dementia and Alzheimer’s in Elderly Patients

Shireen Alzidjali, Clinical Pharmacist, Sultan Qaboos university Hospital, Oman
12:45-13:00 Managing Poly-Pharmacy Prescription in Al Masarra Hospital

Isra Al Lawati, clinical pharmacist, DGMS, Oman
13:00-13:15 Development & Implementation of Strategic Frameworks for Polypharmacy Management in Health Care Organizations

Sara Al-balushi, Sr. Specialist Pharmacist Director pharmaceutical Care. MOH.Oman
13:15-13:30 Building a Patient Safety Savvy Pharmacist Workforce in Oman: Academic Institutions Play a leading Role

Jimmy Jose, Associate Professor of pharmacy Practice, school of pharmacy, University of Nizwa. Oman
13:30-13:45 Survey Based Study on Medication Reconciliation at Tertiary Care Hospital in Muscat

Yumna Jadallah, College of Pharmacy National University of Science and technology. Oman
13:45-14:00 Optimizing Safe Utilization of Covid-19 Medication in the Royal Hospital

Umkulthum Salim Albarwani, senior specialized pharmacist, MSc in clinical pharmacy MPharm Head of National Heart center pharmacy
14:00 –14:10 Discussion
14:00-15:00 Lunch and Prayer Break

Parallel Session: ASHP Program Expanding Clinical Pharmacy Services

@Grand Ball Room (Hall B)

Moderator: Charles Daniels
Type of Session: Knowledge – Based

Session Program:

Time Topic
11:00-11:20 Building and Expanding Clinical Pharmacy Services

Paul Bush, Pharm.D., M.B.A., BCPS, FASHP Vice President, Global Business Development and Consulting American Society of Health System Pharmacists
11:20- 11:40 ASHP Vision for Pharmacy Workforce in Hospitals and Health Systems

Anna Legreid Dopp, PharmD, CPHQ Senior Director, Clinical Guidelines and Quality Improvement, ASHP
11:40-12:00 Developing Pharmacist Competencies for Clinical and Specialty Pharmacy

Paul W. Bush, PharmD, MBA, BCPS, FASHP Vice President, Global Resource Development and Consulting, ASHP
12:00-12:20 The Safety of Intravenous Drug Delivery Systems: Update on Issues Since the 2009 Consensus Development Conference

John Hertig, PharmD, MS, CPPS, FASHP Associate Professor and Vice-Chair of Pharmacy Practice Butler University College of Pharmacy and Health Sciences
12:20-12:30 Discussion

Parallel Session: Therapeutic Advances and Disease Management

@Grand Ball Room (Hall B)

Moderator: Osama Tabara
Type of Session: Knowledge – Based

Session Program:

Time Topic
12:30-12:45 Cardio – oncology challenges in the era of novel therapies

Nora Al-khudair, BScPharm, PharmD, Assistant Professor of Clinical Pharmacy College of Pharmacy ,King Saud University Hematology, Oncology and SCT Clinical Pharmacist at KSUMC,KSA
12:45-13:00 New Antibiotics for MDR Gram-negative pathogens

Khalid Eljaaly, PharmD, MS, BCPS, BCIDP Associate Professor and Consultant Infectious Disease Pharmacist at King Abdulaziz University, and Chairman of Infectious Disease PSN of Saudi Society of Clinical Pharmacy, KSA.
13:00-13:15 Drug Resistant Epilepsy- Medical Management

Haifa Al-Abri, MD, Consultant Adult Neurology /Epilepsy and Neurophysiology , Sultan Qaboos University Hospital ,Oman
13:15-13:25 TPN in Neonates and Pediatrics: Optimizing Therapy and Preventing Complication

Faisal A. AlSehli, BSc, MSc, HSQM, PharmD Department of Clinical Pharmacy King Abdulaziz Medical City. KSA
13:25-13:30 Discussion
15:00-16:00 Lunch